Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01041079 · ClinicalTrials.gov registry record
Chronic Marginal Ulcers After Gastric Bypass
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 50
- Enrollment target
NCT01041079: Completed study, sponsored by University of California, San Francisco.
NCT01041079 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01041079 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility, safety, and efficacy of revision gastroplasty along with other adjunct procedures in the treatment of intractable / chronic marginal ulcers after Roux-en-Y gastric bypass. A secondary aim is the identification of good and poor outcome predictors after revisional strategies for intractable or chronic marginal ulcer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-12 |
What the finished NCT01041079 record still lists
NCT01041079 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01041079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01041079 about?
NCT01041079 is a clinical study titled "Chronic Marginal Ulcers After Gastric Bypass". The purpose of this study is to determine the feasibility, safety, and efficacy of revision gastroplasty along with other adjunct procedures in the treatment of intractable / chronic marginal ulcers after Roux-en-Y gastric bypass. A secondary aim is the identification of good and poor outcome predic...
What is the current status of trial NCT01041079?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2008-12. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT01041079?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia